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ABSTRACT The mutations in the GJB2 (Сх26) gene make the biggest contribution to hereditary hearing loss. The 
spectrum and prevalence of the GJB2 gene mutations are specific to populations of different ethnic origins. For 
several GJB2 mutations, their origin from appropriate ancestral founder chromosome was shown, approximate 
estimations of “age” obtained, and presumable regions of their origin outlined. This work presents the results 
of the carrier frequencies’ analysis of the major (for European countries) mutation c.35delG (GJB2 gene) among 
2,308 healthy individuals from 18 Eurasian populations of different ethnic origins: Bashkirs, Tatars, Chuvashs, 
Udmurts, Komi-Permyaks, Mordvins, and Russians (the Volga-Ural region of Russia); Byelorussians, Ukrain-
ians (Eastern Europe); Abkhazians, Avars, Cherkessians, and Ingushes (Caucasus); Kazakhs, Uzbeks, Uighurs 
(Central Asia); and Yakuts, and Altaians (Siberia). The prevalence of the c.35delG mutation in the studied ethnic 
groups may act as additional evidence for a prospective role of the founder effect in the origin and distribution 
of this mutation in various populations worldwide. The haplotype analysis of chromosomes with the c.35delG 
mutation in patients with nonsyndromic sensorineural hearing loss (N=112) and in population samples (N =358) 
permitted the reconstruction of an ancestral haplotype with this mutation, established the common origin of the 
majority of the studied mutant chromosomes, and provided the estimated time of the c.35delG mutation carriers 
expansion (11,800 years) on the territory of the Volga-Ural region.
KEYWORDS hereditary nonsyndromic sensorineural hearing loss; GJB2 (Cx26) gene; c.35delG mutation; ances-
tral haplotype; populations of the Volga-Ural region.
INTRODUCTION
Hereditary deafness is a frequent disorder in humans: 
it is recorded in 1/1,000 newborns. The etiology and 
pathogenesis of this disease are still to be clarified; 
however, approximately half of the cases of hereditary 
deafness are a result of genetic disorders [1].
The hereditary forms of innate hearing loss are char-
acterized by clinical polymorphism and genetic hetero-
geneity. In the nuclear genome, about 114 loci were 
mapped and 55 genes were identified, whose muta-
tions to a certain extent cause hearing loss. About 80% 
of all cases of hereditary nonsyndromic hearing loss 
fall within the category of autosomal-recessive forms; 
15–20% – autosomal-dominant, and about 1% - the 
form linked with the Х-chromosome and mitochondrial 
forms of deafness [2].
The most frequent cause of nonsyndromic autosom-
al recessive hearing loss in humans is the mutations in 
the GJB2 gene (gap junction β2, subunit β2 of the gap 
junction protein), localized in the chromosomal region 
13q11–q13 and coding connexin 26 (Сх26), which is 
the transmembrane protein involved in the formation 
of connexons. Connexons are structures consisting of 
six protein subunits, which form cellular channels, en-
suring a fullblown ion exchange among adjacent cells. 
This facilitates the maintenance of the homeostasis of 
endolymph in cochlea tissues. Recently, the fine struc-
ture of intercellular channels formed by connexin 26 RESEARCH ARTICLES
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was reported (Fig. 1) [3]. When there are defects in 
connexin 26, the functioning of the intercellular chan-
nels is irreversibly disrupted in the tissues of the in-
ternal ear and endolymph homeostasis is not restored: 
a factor that is necessary for normal sound perception 
[4].
So far, in the GJB2 gene, over 150 pathogenic muta-
tions (mainly recessive), several polymorphisms and 
sequencing variants whose role in the pathogenesis of 
hearing loss is still unclear, have been described [2]. The 
spectrum and frequencies of the GJB2 gene mutations 
are characterized by significant interpopulation differ-
ences. The racial and/or ethnic specificity of the spread 
of several GJB2 gene mutations is preconditioned in 
some cases by the founder effect, as well as by, in all 
likelihood, the geographic and social isolation of some 
populations. Researchers have managed to show the 
origin of some GJB2 gene mutations from an ancestor 
founder chromosome, to obtain approximate estima-
tions of the “age” of the mutations, and to outline sug-
gested regions where they appeared [5–10]. The mu-
tation c.35delG (p.Gly12Valfsx1) is the most frequent 
in Europe. It first emerged, according to various esti-
mates, 10,000 to 14,000 years ago on the territory of the 
Middle East or Mediterranean region (probably on the 
territory of modern Greece) [10–12] and spread in Eu-
rope with the migrations of the neolithic population of 
Homo sapiens [6]. Haplotype analysis of the chromo-
somes with mutation c.235delC (p.Leu79Cysfsx3) in 
populations of Japan, Korea, China, and Mongolia has 
allowed to put forward a hypothesis about the founder 
effect regarding the origin and distribution of this mu-
tation in East Asia and to estimate its “age” (~11,500 
years) and presumed appearance in the Lake Baikal re-
gion, from where it spread, by way of sequential migra-
tions, over Asia [7]. The “age” of the mutation c.71G>A 
(p.Trp24X), most widespread in India, has also been as-
sessed (~7,880 years) [8]. The ethnic specificity of the 
mutation c.167delT (p.Leu56Argfsx26) and mutation 
c.427C > T (p.Arg143Trp) was shown for populations 
of the Ashkenazi Jews [5] and for some populations of 
Western Africa (Ghana) [13, 14], respectively. 
In Russia, several research groups have studied the 
hereditary forms of deafness [15–32]. In most cases, 
they have considered the genetic-epidemiological and 
clinical-genetic peculiarities of the inherited forms 
of hearing loss, and a series of papers are devoted to 
the molecular-genetic analysis of the GJB2 gene or its 
single mutations [17–21, 25–30]. Some authors have 
obtained data on the specificity of the range and fre-
quency of separate mutations in the GJB2 gene func-
tion in the studied region. For instance, the most fre-
quent mutations in the Siberian populations (Yakuts 
and Altaians) are IVS1 + 1G>A [27] and c.235delC [25], 
respectively. The populations of the Volga-Ural region, 
as generally in the European part of the continent, 
predominantly exhibit the mutation c.35delG [18–22, 
28]. Local differences in the carrier frequency of the 
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mutation c.35delG are probably related to the genetic 
history of some populations, and factors of population 
dynamics, and migration routеs of the с.35delG carriers 
in the world. The available data on the contribution of 
the GJB2 mutations to the development of a pathology 
in patients with nonsyndromic sensorineural hearing 
loss (NSHL), living in the Volga-Ural regions, and the 
population-based data on the carrier frequency of the 
most significant recessive mutation c.35delG permit-
ted an adequate assessment of the haplotypic diversity 
of the chromosomes bearing the mutation  с.35delG, 
the reconstruction of the possible ancestor haplotype 
linked to that mutations, and the estimated time of its 
appearance on the territory of the Volga-Ural regions, 
which represents the eastern border of the habitat of 
the mutation с.35delG.
EXPERIMENT
The material taken for the haplotypic analysis and es-
timates of the “age” of c.35delG of the gene GJB2 was 
56 DNA samples (112 chromosomes) obtained from pa-
tients with NSHL, residing in the Volga-Ural regions, 
in which the mutation.35delG was identified in the ho-
mozygote state (32 Russians, 10 Tatars, 1 Bashkirs, 4 
Ukrainians, 2 Armenians, and 7 individuals of mixed 
ethnicity). The control group included 179 (358 chromo-
somes) healthy individuals from three ethno-geograph-
ical groups of the Russians (N = 86); Tatars (N = 62); 
and Bashkirs (N = 31) without this mutation.
To analyze the carrier frequency of c.35delG 2,308 
DNA samples were used, which were obtained from 
healthy individuals-representatives of different popu-
lations of the Volga-Ural region, Central Asia, North-
ern Caucasus, Eastern Europe, and Siberia, belonging 
to four language families (Table 1). 
The blood samples were obtained during expedi-
tions between the years of 2000 and 2010, after receiv-
ing the informed written consent of the participants in 
the study. The genomic DNA was extracted from pe-
ripheral blood using the phenol-chloroform extraction 
method.
The present scientific-research work was approved 
by the local committee for biomedical ethics at the IBG 
UNT of the Russian Academy of Sciences (Ufa). 
Screening of the с.35delG mutation in the GJB2 gene
The screening of the mutation с.35delG in the GJB2 
gene was carried out with the allele-specific amplifi-
cation of fragments of the coding region of the GJB2 
gene using the primers listed in  Table 2. The results 
were visualized by vertical electrophoresis in a 10% 
polyacrylamide gel (PAAG) with further staining of 
the ethidium bromide solution in the standard concen-
tration and viewing in ultraviolet rays.
Analysis of haplotypes and estimate of 
the “age” of the mutation c.35delG
For the analysis of the haplotypes and the estimated 
age of the mutation c.35delG in the GJB2 gene, three 
high-polymorphic microsatellite СА-markers were 
used: D13S175, D13S141, and D13S143 [6, 9, 10, 12, 36], 
flanking the DFNB1 locus, which contains the GJB2 
gene. The physical and genetic localization of the mark-
ers at chromosome 13 and genetic distances between 
them, as well as the GJB2 gene, were identified on the 
basis of the Marshfield genetic linkage map (http://
www.ncbi.nlm.nih.gov/mapview/). The total physical 
distance of the flanked region was ~ 2  Mb. (Fig. 2). The 
choice of the markers was preconditioned to fall with 
the strive to get the possibility of comparable data, as 
earlier these markers were used for the assessment of 
the age of mutations in the gene GJB2 in different pop-
ulations [6, 9, 10, 12, 36]. 
The STR-markers were genotyped using PCR at the 
thermocycler (Eppendorf), and appropriate oligonu-
cleotide primers were used (Table 2). Products of the 
1.5 Mb. 
38.5 Kb. 84 Kb .
D13S141
(19622459–19622584 b.p.)
1.535 сM (Marshfield)
GJB2  
(19659605–19665114 b.p.)
D13S175
(19746380–19746734 b.p.)
5.94 cM (Marshfield)
D13S143
(21172085–21172213 b.p.)
6.03 cM (Marshfield)
Fig. 2. Localiza-
tion of the micro-  the micro- the micro-
satellite mark-  mark- mark-
ers D13S141, 
D13S175, 
and D13S143, 
flanking the 
GJB2 gene, on 
chromosome 
13. The distance 
between the 
GJB2 gene and 
the markers is 
indicated by ar-  by ar- by ar-
rows.RESEARCH ARTICLES
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Table 1. Carrier frequencies of the c.35delG mutation in 18 ethnic groups dwelling on the territory of Eurasia
Population
Linguistic  
affiliation 
(group) 
Region N
Number of 
heterozygote 
carriers of the 
mutation c.35delG 
/ total numbers of 
individuals tested
(carrier fre-
quency)
Eastern Europe
Byelorussians Indo-European / 
Slavic The Republic of Belarus (disperse sample) 97 6/97
(0.062)
Ukrainians Indo-European / 
Slavic Kharkov region and Poltava region, Ukraine 90 3/90
(0.033)
Volga-Ural region
Russians Indo-European / 
Slavic Yekaterinburg, the Russian Federation (RF) 92 2/92
(0.022)
Bashkirs Altaic / Turkic
Baimakskii, Burzyanskii, Abzelilovskii, Kugarchinskii, 
Salavatskii, and Arkghangelskii districts, the Republic of 
Bashkortostan, RF
400 1/400
(0.003)
Tatars Altaic / Turkic Al’met’evskii and Yelabuzhskii districts, the Republic of 
Tatarstan, RF 96 1/96
(0.010)
Chuvashs Altaic / Turkic Morgaushskii district, the Chuvash Republic, RF 100 0/100
Mordvins Uralic / Finno-
Ugric Staroshaiginskii district, the Republic of Mordovia, RF 80 5/80
(0.062)
Udmurts Uralic / Finno-
Ugric
Malopurginskii district of the Udmurt Republic and 
Tatyshlinskii district of the Republic of Bashkortostan, RF 80 3/80
(0.037)
Komi-
Permyaks
Uralic / Finno-
Ugric
Kachaevskii district, the Komy-Permyak Autonomous 
District, RF 80 0/80
Central Asia
Kazakhs Altaic / Turkic Alma-Atinskaya region, Kyzylordinskaya region, and Abaiskii 
district, Kazakhstan 240 2/240
(0.008)
Uighurs Altaic / Turkic Alma-Atinskaya region, Kazakhstan 116 1/116
(0.009)
Uzbeks Altaic / Turkic The Republic of Uzbekistan (disperse sample) 60 0/60
Caucasus
Abkhazians North-Caucasian 
/ Adygo-Abkhaz Abkhazia and Georgia (disperse sample) 80 3/80
(0.038)
Avars North-Caucasian 
/ Dagestan Gumbetovskii district, the Republic of Dagestan, RF 60 0/60
Cherkessians  North-Caucasian 
/ Adygo-Abkhaz The Karachaevo-Cherkess Republic, RF 80 1/80
(0.013)
Ingushes North-Caucasian 
/ Nakh Nazran’ district, the Republic of Ingushetia, RF 80 0/80
Siberia
Altaians Altaic / Turkic The Republic of Altai, RF 230 0/230
Yakuts Altaic / Turkic
Megino-Kangalasskii, Amginskii, Churapchinskii, Tattinskii, 
Verkhnevilyuiskii, Vilyuiskii, Nyurbinskii, and Suntarskii 
uluses (districts), the Republic of Sakha (Yakutia), RF
247 1/247
(0.004)56 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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PCR-reaction were separated by vertical electrophore-
sis (glass size 20 × 20 cm, Helicon, Russia) in 10% PAAG 
and 5% glycerin. The gels were stained with silver ions. 
The linkage disequilibrium between alleles of the 
13th-chromosome loci was calculated using the follow-
ing formula: 
δ = (Pd– Pn)/(1 – Pn),
where δ is the measure of linkage disequilibrium, Pd 
is the frequency of the associated allele among mutant 
chromosomes, and Pn is the frequency of the same al-
lele among intact chromosomes [37].
The statistical significance of differences in the fre-
quencies of the alleles of the studied markers on 112 
chromosomes containing c.35delG and 358 chromo-
somes without this mutation was assessed using the 
standard χ2 test 2х2 (the MedStat software).
The age of expansion of the founder haplotype bear-
ing the mutation с.35delG in the GJB2 gene was es-
timated via the genetic clock approach [38], which is 
based on the definition of the number of generations 
(q) from the moment of the mutation appearance in the 
population to the present, proceeding from the ratio of 
linkage disequilibrium in terms of polymorphous mark-
ers linkage with the locus of the disorder. This age was 
calculated using the following formula:
q = log[1 – Q/(1 – Pn)]/log(1 – Ө),
where q is the number of generations since the moment 
the mutation appeared in the population, Q is the share 
of mutant chromosomes without the founder haplo-
type, Pn is the frequency of the allele of the founder 
haplotype in the population, and Ө is the recombinant 
fraction. The value of Ө was computed given the physi- was computed given the physi-
cal distance of the markers from the location of the mu-
tation, stemming from the ratio 1 cM = 1,000,000 b.p.
The value for the allele association was estimated by 
the coefficient of standard linkage disequilibrium ac-
cording to [39]:
ΔSt
pq
pq pq
=
−
+ −− ( )( ) 2
,
where р and q are the frequencies of the alleles or hap-
lotypes of the normal (р) and mutant (q) chromosomes.
The haplotypic diversity indicator equivalent to the 
expected heterozygosity was calculated using the for-
mula:
 h xN N i = −− ∑ ( ) /( ) 11
2 ,
where х is the frequency of each haplotype in the pop-
ulation, and N is the sample size [40].
RESULTS AND DISCUSSION
In many populations worldwide, the main contribu-
tor to the development of nonsyndromic sensorineural 
hearing loss (NSHL) is the mutations of the GJB2 gene. 
In most European populations, up to 40–50% of cases of 
NSHL are preconditionally caused by one of the major 
recessive mutations of this gene, c.35delG, which is re-
vealed in the homozygous or compound-heterozygous 
state [41]. In connection with this, many researchers 
have analyzed the carrier frequency of c.35delG in a 
variety of populations in the world. A large-scale study 
which embraced 17 European countries showed that 
the mean carrier frequency of the c.35delG  mutation 
amounts to 1.96% (1/51), ranging from 2.86% (1/35) in 
South-European countries to 1.26% (1/79) in Northern 
Europe [42]. In the Mediterranean region, the highest 
carrier frequency of c.35delG were observed in Greece 
(3.5%), in the southern regions of Italy (4.0%), and in 
France (3.4%) [43]. As a result of the meta-analysis of 
the c.35delG carrier frequency in over 23,000 individu-
als from different populations, carried out on the basis 
of the data published between the years of 1998 and 
2008, the average regional frequencies of c.35delG were 
determined in the European (1.89%), American (1.52%), 
Asian (0.64%), and African (0.64%) populations, as well 
as in Oceania (1%). Also, the decreasing gradient of the 
carrier frequency of c.35delG (from 2.48 to 1.53%) from 
Table 2. Sequences of primers used for amplification
Locus Name and nucleotide sequence of primers Detection 
method Reference
GJB2 (13q11-q12) 35delG F 5’-CTTTTCCAGAGCAAACCGCCC-3’
35delG R 5’-TGCTGGTGGAGTGTTTGTTCAC-3’
Visualization of 
PCR fragments 
in 10% PAAG
[15]
D13S141 F- 5’-GTCCTCCCGGCCTAGTCTTA-3’
R-5’-ACCACGGAGCAAAGAACAGA-3’ [33]
D13S143 F-5’-CTC ATG GGC AGT AAC AAC AAAA-3’
R-5’-CTT ATT TCT CTA GGG GCC AGC T-3’ [34]
D13S175 F-5’-TAT TGG ATA CTT GAA TCT GCT G-3’
R-5’-TGC ATC ACC TCA CAT AGG TTA-3’ [35]RESEARCH ARTICLES
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south to north in European populations and from west 
to east (from 1.48 to 0.1%) in Asian populations [44] was 
confirmed.
Carrier frequency of the mutation c.35delG
An analysis of the carrier frequency of the mutation 
c.35delG in 18 populations of Russia and the former So-
viet states was carried out (Table 1). 
High carrier frequencies of the c.35delG were re-
vealed in two Eastern European populations: Ukrai-
nians (3.3%) and Byelorussians (6.2%). In the Turkic-
speaking populations of the Volga-Ural region, the 
carrier frequencies of the mutation с.35delG were 1.0, 
0.3, and 0% in Tatars, Bashkirs and Chuvashs, respec-
tively. In the Finno-Ugric populations of the Volga-Ural 
region, the с.35delG mutation was present with a high 
carrier frequency of 6.2% in Mordvins, 3.7% in Udmurts, 
and it was absent in Komi-Permyaks. These frequency 
fluctuations among the studied populations of the Vol-
ga-Ural region are likely due to the specific features of 
the historic development of these populations in the re-
gion, or could be the consequence of the relatively small 
size of the samples. Earlier, a high carrier frequency 
of с.35delG (4.4%) was found in Estonians, an appar- с.35delG (4.4%) was found in Estonians, an appar- .35delG (4.4%) was found in Estonians, an appar-
ent exception for Northern European populations, who 
typically have low frequencies of с.35delG [42]. These 
data, as well as the data obtained during other studies 
[15, 20–22, 28, 29], indicate the significant variation in 
the carrier frequency of с.35delG among indigenous 
populations of the Volga-Ural region. The carrier fre-
quency of the с.35delG, singled out in Russians (2.2%), 
was comparable to the results for the Russian popula-
tion in the Central region of Russia [15, 18, 28]. In the 
Turkic-speaking populations of Central Asia (Kazakhs, 
Uighurs, and Uzbeks) the mutation c.35delG with a low 
carrier frequency was observed in Kazakhs (0.8%), Ui-
ghurs (0.9%), and it was absent in Uzbeks. In the Tur-
kic-speaking populations of Siberia (Yakuts and Alta-
ians) a relatively low carrier frequency of the mutation 
c.35delG (0.4%) was revealed in the Yakut population 
but was not detected in Altaians. The North Caucasus 
region was in the past one of the crucial migration cor-
ridors in Eurasia. It is characterized by a high diversity 
of the population and a complex historical development 
of its resident ethnoses. In the North Caucasus popula-
tions (Abkhazians, Avars, Cherkessians, and Ingushes), 
the mutation с.35delG was discovered only in Abkhaz- с.35delG was discovered only in Abkhaz- .35delG was discovered only in Abkhaz-
ians (3.8%) and Cherkessians (1.3%).
The spatial distribution of the carrier frequency of 
the mutation in the Eurasian populations obtained on 
the basis of our own data and that of relevant published 
information on the c.35delG available as of 2010 [24] is 
presented in Fig. 3.
The data obtained significantly added to the picture 
of the mutation c.35delG distribution in Eurasia: Eu-
ropean regions of Russia, just as the European part of 
the continent on the whole, are characterized by a high 
frequency of с.35delG, and this mutation is widespread 
in the polyethnic population of the Volga-Ural region. 
However, the mechanisms of its spreading and time of 
appearance in the Volga-Ural region are yet to be stud-
ied. To answer these questions, we carried out a hap-
lotypic analysis of the chromosomes carrying c.35delG 
and those without it, using three high-polymorphous 
microsatellite СА-markers: D13S175, D13S141, and 
D13S143 [6, 9, 10, 12, 36], which flank the locus DFNB1 
containing the GJB2 gene (Fig. 2). 
Frequencies of alleles of loci D13S141, 
D13S175, and D13S143
Table 3 lists the distribution of frequencies for the al-
leles of microsatellite markers D13S141, D13S175, and 
D13S143 in the NSHL patients (c.35delG-mutant chro-
mosomes) and in the control sample (normal chromo-
somes), including three ethnic groups (Russians, Tatars, 
and Bashkirs).
In other studies, the area sized 2  Mb and covered 
by these three markers allowed for the calculation of 
the approximate number of past generations since the 
start of the expansion of the proposed founder hap-
lotype, including mutations of the GJB2 gene, in the 
populations of India (mutation p.Trp24X) [8] and Mo-
rocco (c.35delG) [9]. A panel consisting of 8 STR-mark-
ers (D4S189, D13S1316, D13S141, D13S175, D13S1853, 
D13S143, D13S1275, and D13S292) and 2 SNP-markers 
was applied in dating the splicing site IVS1 + 1G>A 
mutation of the GJB2 gene in the Yakut population [27]. 
The age of the mutations c.35delG and с.235delC was 
computed using the 6 SNP-markers [6, 7]. In later stud-
Fig. 3.The spatial distribution of the carrier frequency of 
the c.35delG  mutation in the GJB2 gene in the popula-  in the popula- popula-
tions of Eurasia (performed using the program SURFER 9.0 
Golden Software Ink).58 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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ies aimed at clarifying the age of the mutation c.35delG 
in Greece, two STR-markers, D13S175 and D13S141, 
and six SNP-markers were used [12].
D13S141. The marker D13S141 has seven allelic vari-
ants [9, 12]; however, only four of them were revealed 
in the ethnic groups from the Volga-Ural region. The 
allele 123 (D13S141) frequency is significantly higher 
(χ2 = 43.458; р = 0.000) on chromosomes of individuals 
from the control group (59%), whereas in NSHL patients, 
it is only 23%. The allele 125 (D13S141) is observed in the 
mutant chromosomes with a frequency of 75%, which is 
significantly higher than in normal chromosomes (31%) 
(χ2 = 67.058; р = 0.000), and it matches the data on the 
allele 125 (D13S141) dominance on chromosomes with 
the mutation с.35delG in NSHL patients from Morocco, 
Greece, Palestine, and Israel [9, 10, 12, 45].
D13S175. The marker D13S175 has eight allelic vari-
ants [9, 10, 12], of which seven are present in the eth-
nic groups of the Volga-Ural region. The allele 105 
(D13S175) on c.35delG chromosomes is observed at 
a frequency of 81.2%, which is significantly higher 
in comparison with the normal chromosomes (43.8%) 
(χ2 = 47.866; р = 0.000), and allele 103 (D13S175) was 
significantly more frequent in the controls (χ2 = 47.866; 
р = 0.000 and χ2 = 15.87; р = 0.000, respectively) (Ta-
ble. 3). Earlier, it was shown that, on the chromosomes 
with the mutation с.35delG in NSHL individuals from 
Tunisia, Algeria, Morocco, and Greece, allele 105 
Table 3. Distribution of allele frequencies of microsatellite markers D13S141, D13S175, and D13S143 in patients with 
NSHL (chromosomes with the c.35delG mutation) and in the control sample (normal chromosomes)
Allele (b.p.)
Chromosomes with c.35delG 
mutation 
(N=112)
Normal chromosomes
(N=358)
χ2
Р
(95% signifi-
cance level) Number of 
chromosomes
Allele  
frequency
Number of 
chromosomes
Allele  
frequency
D13S141
113 0 0 10 0.027±0.008 0.3131 0.6
123 26 0.232±0.031 211 0.589±0.026 43.458 0.000
125 84 0.750±0.042 112 0.312±0.024 67.058 0.000
127 2 0.017±0.002 25 0.069±0.013 4.2629 0.045
D13S175
101 3 0.026±0.012 21 0.058±0.01 1.793 0.300
103 8 0.071±0.021 88 0.245±0.02 15.875 0.000
105 91 0.812±0.036 157 0.438±0.02 47.866 0.000
107 1 0.008±0.007 30 0.083±0.01 7.763 0.005
109 6 0.053±0.024 38 0.106±0.01 2.783 0.100
111 0 0 7 0.019±0.007 2.222 0.150
113 3 0.026±0.01 17 0.047±0.01 0.897 0.064
D13S143
126 1 0.008±0.007 0 0 3.192 0.04
128 1 0.008±0.007 5 0.013±0.006 0.169 0.65
130 90 0.80±0.048 283 0.79±0.021 0.088 0.81
132 6 0.05±0.026 26 0.07±0.013 0.490 0.54
134 12 0.11±0.016 37 0.10±0.013 0.012 0.89
136 2 0.017±0.021 3 0.008±0.004 0.727 0.55
138 0 0 4 0.011±0.005 3.278 0.05RESEARCH ARTICLES
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(D13S175) was also very frequent (from 67 to 100%) 
[9, 12, 46]. Allele 111 (D13S175) was not observed on 
the chromosomes of individuals with NSHL but it was 
present in 2% of the chromosomes of people with no 
hearing problems.
D13S143. The marker D13S143 has eight allelic variants 
[9, 12], of which seven are present in the ethnic groups 
residing in the Volga-Ural region. Allele 130 (D13S143) 
is the most frequent both on normal chromosomes 
(79%) and c.35delG chromosomes (80%), and allele 134 
(D13S143) is more often detected on chromosomes of 
с.35delG-mutant individuals (χ2 = 9.909; р = 0.005). 
An analysis of the distribution of the allele frequen-
cies of three microsatellite loci D13S141, D13S175, and 
D13S143 on normal and  с.35delG chromosomes re- с.35delG chromosomes re- .35delG chromosomes re-
vealed a pronounced misbalance in linkage between the 
specific alleles of these markers and mutation с.35delG 
in the GJB2 gene (Table. 3). The degree of association 
of the out-gene microsatellite loci under study vividly 
reflects the standard coefficient of the allele associa-
tion (∆St) [39]. The greatest degree of linkage with the 
mutation с.35delG is typical of allele 125 of the marker 
D13S141 (∆St = -0.438) and allele 105 of the marker 
D13S175 (∆St = -0.386). 
Haplotype analysis and age of с.35delG mutation
Given the data we obtained during the study of the 
polymorphism of the markers D13S141, D13S175, and 
D13S143, and the linkage disequilibrium of some of 
their alleles with the mutation с.35delG in the GJB2 
coding region, we suggested that they may be evidence 
of the presence of a single ancestor haplotype, which 
carries this mutation. As a result, for three polymorphic 
loci, haplotypes of members of each of the 56 families 
with hereditary deafness and healthy donors were con-
structed. A precise identification of the haplotype by 
the alleles D13S175–D13S143–D13S141 is possible for 
112 mutant chromosomes with с.35delG and 358 nor- с.35delG and 358 nor- .35delG and 358 nor-
mal chromosomes.
In all of the chromosomes analyzed, 59 different 
variants of haplotypes were revealed, of which 52 were 
found on normal chromosomes and 25 on  с.35delG-
mutant chromosomes (Table 4). 
The distribution of the haplotypes on 358 normal 
chromosomes is characterized by a high value of hap-
lotypic diversity (h = 0.943), the frequency of the most 
wide-spread haplotype 123-105-130 amounts to 17.8%, 
and 11 other haplotypes are found at frequencies ex-
ceeding 2%. For the distribution of haplotype frequen-
cies on 112 chromosomes with the mutation c.35delG, 
a lower value of the haplotypic diversity (h = 0.645) 
is typical, the haplotype 125-105-130 is the most fre-
quently found (59%), and the frequency of six haplo-
types exceeds 2%. Seven haplotypes rarely occurring on 
the mutant chromosomes (below 2%) were not detected 
on normal chromosomes. The graphic mapping of the 
occurrences of the haplotypes D13S141–D13S175–
D13S143 on the normal chromosomes of healthy donors 
and с.35delG-mutant chromosomes in NSHL patients is 
illustrated in Fig. 4.
An analysis of the distribution of the haplotypes 
D13S141–D13S175–D13S143 on normal chromosomes 
in people of different ethnic origins (Russians, Tatars, 
and Bashkirs) showed differences in the spectrum of 
haplotypes in the surveyed ethnic groups and statisti-
cally significant differences in the frequencies of the 
haplotypes (χ2 = 57.335; р = 0.000; d.f. = 56). In Russians 
Fig. 4. The distribution 
of frequencies of haplo-  of haplo- of haplo-
type D13D141-D13S175-
D13S143 on normal chromo-  on normal chromo- on normal chromo-  normal chromo- normal chromo-  chromo- chromo-
somes and chromosomes 
with a mutation c.35delG in 
patients with NSHL (non-
syndromic sensorineural 
hearing loss). Along the 
vertical and horizontal axes 
the frequency of the haplo-  the haplo- haplo-
type and the names of the 
haplotype are indicated, 
respectively. The arrow 
shows the haplotype 125-
105-130.
Chromosomes with c.35delG mutation
Normal chromosomes
Haplotype  
125-105-13060 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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Table 4. Frequencies of haplotypes D13S141-D13S175-D13S143, identified in chromosomes of patients with the 
с.35delG / с.35delG genotype and in normal chromosomes of healthy donors living in the Volga-Ural region
Haplotypes
Patients with 
c.35delG\c.35delG Overall control Russians Tatars Bashkirs
Absolute 
value Frequency Absolute 
value Frequency Absolute 
value Frequency Absolute 
value Frequency Absolute 
value Frequency
113-101-130 1 0.009 1 0.002 0 0 1 0.008 0 0
123-101-130 1 0.009 12 0.033 4 0.023 7 0.056 1 0.016
125-101-130 0 0 4 0.011 4 0.023 0 0 0 0
113-101-134 1 0.009 0 0 0 0 0 0 0 0
125-101-136 0 0 1 0.002 1 0.006 0 0 0 0
123-103-128 0 0 1 0.002 0 0 1 0.008 0 0
113-103-130 0 0 3 0.008 2 0.012 1 0.008 0 0
123-103-130 2 0.018 28 0.078 13 0.076 12 0.097 3 0.048
125-103-130 1 0.009 20 0.055 12 0.070 4 0.032 4 0.064
127-103-130 0 0 5 0.013 4 0.023 0 0 1 0.016
113-103-132 0 0 1 0.002 0 0 1 0.008 0 0
123-103-132 0 0 1 0.002 0 0 1 0.008 0 0
125-103-132 0 0 2 0.005 1 0.006 1 0.008 0 0
123-103-134 3 0.027 8 0.022 2 0.012 4 0.032 2 0.032
125-103-134 0 0 3 0.008 3 0.017 0 0 0 0
125-103-136 1 0.009 0 0 0 0 0 0 0 0
123-103-138 0 0 1 0.002 0 0 1 0.008 0 0
125-105-128 1 0.009 0 0 0 0 0 0 0 0
123-105-128 2 0.018 0 0 0 0 0 0 0 0
113-105-130 1 0.009 3 0.008 3 0.017 0 0 0 0
123-105-130 8 0.071 64 0.178 25 0.145 24 0.194 15 0.242
125-105-130 66 0.590 35 0.097 24 0.140 5 0.040 6 0.097
127-105-130 0 0 3 0.008 3 0.017 0 0 0 0
113-105-132 1 0.009 0 0 0 0 0 0 0 0
123-105-132 1 0.009 3 0.008 0 0 2 0.016 1 0.016
125-105-132 4 0.036 1 0.002 1 0.006 0 0 0 0
127-105-132 0 0 2 0.005 2 0.012 0 0 0
123-105-134 3 0.027 9 0.025 3 0.017 4 0.032 2 0.032
125-105-134 5 0.045 4 0.011 3 0.017 1 0.008 0 0
127-105-134 0 0 1 0.002 0 0 1 0.008 0 0
123-105-136 0 0 2 0.005 0 0 2 0.016 0 0
125-105-138 0 0 1 0.002 0 0 1 0.008 0 0
123-105-138 0 0 1 0.002 1 0.006 0 0 0 0
113-107-130 0 0 1 0.002 0 0 1 0.008 0 0
123-107-130 1 0.009 16 0.044 4 0.023 4 0.032 8 0.129
125-107-130 0 0 1 0.002 1 0.006 0 0 0 0
123-107-128 0 0 1 0.002 0 0 0 0 1 0.016
125-107-128 0 0 1 0.002 0 0 1 0.008 0 0
127-107-130 0 0 2 0.005 0 0 2 0.016 0 0
123-107-132 0 0 1 0.002 0 0 1 0.008 0 0
123-107-134 0 0 1 0.002 0 0 1 0.008 0 0
125-109-126 1 0.009 0 0 0 0 0 0 0 0
123-109-130 1 0.009 16 0.044 9 0.052 4 0.032 3 0.048
125-109-130 2 0.018 7 0.019 6 0.035 1 0.008 0 0
127-109-130 0 0 1 0.002 1 0.006 0 0 0 0
123-109-132 0 0 2 0.005 1 0.006 1 0.008 0 0
125-109-132 0 0 1 0.002 1 0.006 0 0 0 0
127-109-134 1 0.009 1 0.002 0 0 0 0 1 0.016
125-109-134 0 0 1 0.002 1 0.006 0 0 0 0
123-109-134 0 0 1 0.002 1 0.006 0 0 0 0
123-109-136 1 0.009 0 0 0 0 0 0 0 0
125-109-138 0 0 1 0.002 1 0.006 0 0 0 0
123-111-130 0 0 3 0.008 0 0 3 0.024 0 0
127-111-130 0 0 2 0.005 1 0.006 0 0 1 0.016
123-111-134 0 0 1 0.002 0 0 1 0.008 0 0
125-111-134 0 0 1 0.002 0 0 0 0 1 0.016
123-113-130 2 0.018 8 0.022 6 0.035 1 0.008 1 0.016
125-113-130 1 0.009 3 0.008 2 0.012 1 0.008 0 0
123-113-134 0 0 1 0.002 0 0 0 0 1 0.016
Haplotypic 
diversity 0.645 0.943 0.944 0.917 0.946
Total,  
chromosomes 112 358 172 124 62
Number of hap-
lotype variants 25 52 32 32 16RESEARCH ARTICLES
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(172 analyzed chromosomes), 32 of the 59 haplotypes 
were revealed in the total sample; in Tatars (124 chro-
mosomes analyzed), 32 of the 59; and in Bashkirs (62 
chromosomes), 17 of the 59 haplotypes.
In Russians, the most widespread haplotypes were 
123-105-130 (14.5%), 125-105-130 (14.0%), and 123-103-
130 (7.6%), while the remaining 29 occurred at different 
frequencies: from 0.6% (12 haplotypes) to 7.0% (haplo-
type 125-103-130). On normal chromosomes in Tatars, 
the haplotypes 123-105-130 and 123-103-130 occurred 
most often at frequencies of 19.4 and 9.7%, respectively, 
and the frequencies of the remaining 30 varied from 
0.8% (19 haplotypes) to 5.6% (haplotype 123-101-130). 
In Bashkirs, the haplotypes 123-105-130 (24.2%), 123-
107-130 (12.9%) and 125-105-130 (9.7%) were most of-
ten recorded, and their total frequency reached 46.8%. 
The frequencies of the remaining 14 haplotypes varied 
from 1.6% (9 haplotypes) to 6.4% (haplotype 125-103-
130). Besides, in each ethnic group, specific haplotypes 
(D13S141–D13S175–D13S143), non-occurring in other 
groups, were observed at low frequencies: in Russians, 
14 haplotypes; in Tatars, 15; and in Bashkirs, 4.
An analysis of the haplotypes D13S141-D13S175-
D13S143 revealed that there is a higher frequency 
of haplotype 125-105-130 on chromosomes with the 
с.35delG mutation compared to the chromosomes of 
healthy donors (χ2 = 64.866, р < 0.001), as well as an eth-
nic specificity of the spectra and frequencies of occur-
rence of the haplotypes D13S141–D13S175–D13S143 
in three ethnic groups of healthy donors.
Table 5 shows data on the association and linkage dis-
equilibrium of marker D13S175, D13S143, and D13S141 
alleles carrying the mutation с.35delG.
The values of the linkage disequilibrium parameter 
were greatest in alleles 105 and 125 of D13S175 and 
D13S141 markers, respectively, located proximally rel-
ative to the gene GJB2, and the lowest in alleles of the 
distal D13S143 marker. Stemming from the values of χ2 
and the linkage disequilibrium parameter δ, the most 
probable founder haplotype (the ancestor haplotype) 
seems to consist of the alleles 125-105-130 (Fig. 4). The 
haplotype 125-105-130 was revealed on 59% of all chro-
mosomes carrying с.35delG, which is reliably higher 
(р < 0.001) than the frequency of this haplotype (9.7%) 
on normal chromosomes.
To calculate the number of generations since the 
start of the spread of the  с.35delG mutation in the 
populations of the Volgo-Ural region, we selected two 
markers: D13S175 and D13S141. The selection crite-
rion for these markers was relatively high values of χ2 
and measure of linkage disequilibrium δ; statistically 
significant differences in the frequency distribution of 
these marker alleles in chromosomes with and without 
с.35delG were also considered.
No statistically significant differences in the fre-
quency distribution of alleles of the marker D13S143 
between c.35delG and intact chromosomes (Table. 3), 
and concurrently a minimum value of the linkage 
disequilibrium parameter, were observed (Table 5). 
The prevalence of the allele 130 of this STR-mark -
er in two groups of chromosomes (with and without 
the с.35delG mutation) formally explains the absence 
of statistically significant differences. Nevertheless, 
given the statistically significant differences obtained 
for two other STR-markers, which are closer to the 
с.35delG mutation, the existence of the ancestor hap- .35delG mutation, the existence of the ancestor hap-
lotype for с.35delG, embracing the area covered by 
the D13S141-D13S175-D13S143 markers, and its 
subsequent “tailing” at the expense of recombination 
and mutation events during the numerous genera -
tions seem likely. However, the absence of a statisti-
cally significant association of the most frequent allele 
130 (D13S143) and the ancestor haplotype provided 
grounds for excluding D13S143 from markers using 
which the number of generations was computed (Ta-
ble 6). 
After the beginning of divergence of the с.35delG-
mutant ancestor haplotype in the populations of the 
Table 6. The number of generations which passed since 
the time of the c.35delG mutation spread in the Volga-
Ural region
Marker
Number of genera-
tion since the time 
of the mutation’s 
appearance in the 
population (q)
Number of 
years which 
passed from 
the start of 
expansion
Start of 
expansion
D13S175 
(allele 105) 470 11800  9800 B.C.
D13S141 
(allele 125) 133 3300  1300 B.C.
Mean 
value 301 7500  5500 B.C.
Table 5. Association and linkage disequilibrium of mark-
ers D13S141, D13S175, and D13S143 with the mutation 
с.35delG
Marker Allele Р (95% signifi-
cance level) χ2 Δ
D13S141 125 <0.001 67.05872 0.636179
D13S175 105 <0.001 47.8665 0.666045
D13S143 130 0.81 0.08801 0.06238162 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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Volga-Ural region, from 133 to 470 generations (on av-
erage 301 generations) passed. At the estimate of the 
age (in years) of the ancestor haplotype reconstructed 
on the territory of the Volga-Ural region, the duration 
of one generation, as in other studies, was considered 
equal to 25 years (Table 6).
The time over which the expansion of the с.35delG-
mutant chromosomes has been present within the 
population of the Volga-Ural region ranges from 3,300-
11,800 years (mean is ~ 7,500). However, such estimates 
of the number of generations (based on the physical 
distance) often lead to the overestimation of the “age” 
of the mutation, because it is the probable (not the ob-
served) value for the mutation events that is consid-
ered; therefore, with this approach, researchers do not 
orientate mean values. Instead, they choose the most 
distant marker, which is linked however to the locus 
of the disease, i.e. the so-called boundary of the sta-
ble haplotype [47]. In the given case, it is the D13S175 
marker. If one presumes that the number of genera-
tions calculated with the use of this marker is more ac-
curate, then the most likely time of expansion of the 
founder haplotype with the mutation с.35delG in the 
populations of the Volga-Ural region is ~ 11,800 years. 
Such dating of the beginning of с.35delG expansion in 
the Volga-Ural region matches the results obtained in 
studies with the use of different DNA markers (SNP- 
and STR-markers) in other populations of Eurasia 
(10,000–14,000 years ago) [9–12].
The results of the haplotype analysis, estimates of 
the age of the c.35delG mutation, and data on the de-
scending gradient to fit carrier frequency from south 
to north in the European populations allow to suggest 
that the Middle East and Mediterranean regions (prob-
ably, modern Greece) are the most probable centers of 
c.35delG origin, from where, together with Neolithic 
migrations of man, it widely propagated throughout 
Europe [9–12]. An analysis of the haplotypic diversity 
(using STR-markers) and approximate assessment of 
the age of c.35delG in the Volga-Ural region favor to 
a great extent the “traditional” Neolithic hypothesis 
about the origin and spread of this mutation. 
Considering the unified time continuum of the start 
of c.35delG spread in Eurasia, obtained with the use 
of various systems of DNA markers (SNP- and STR-
markers), an assessment of the world haplotypic di-
versity of the mutant chromosomes accounting for 
the integral set of DNA markers is required to get an 
unambiguous answer to the question of the center of 
origin of the с.35delG mutation. 
CONCLUSIONS
The analysis of the carrier frequency of the mutation 
c.35delG in the GJB2 gene in Eurasian populations has 
revealed a tendency towards gradient decrease in the 
c.35delG frequency from West to East, starting from 
the populations of Eastern Europe and the Volga-Ural 
region, with average frequencies of 3.3 and 1.4%, re-
spectively; a low frequency (0.8–0.9%) in Central Asian 
populations, a minimum frequency (0.4%) in Yakuts re-
siding in Eastern Siberia; and the absence of с.35delG in 
Altaians (Southern Siberia).
A haplotype analysis of the c.35delG-mutant chromo-
somes has allowed us to reconstruct the ancestor haplo-
type carrying this mutation and to confirm the unified 
origin of most of the studied mutant chromosomes of 
NSHL patients living in the Volga-Ural region. The esti-
mated time of expansion of the c.35delG mutation carri-
ers we obtained (11,800 years ago) fits the world values 
of the “age” of this mutation (10,000–14,000 years). 
The body of data collected should help clarify or re-
view existing ideas about the center and time of origi-
nation of the c.35delG mutation (GJB2), as well as the 
factors that define its occurrence worldwide.  
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